Literature DB >> 16242257

Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.

Shu-lian Wang1, Zhongxing Liao, Ara A Vaporciyan, Susan L Tucker, Helen Liu, Xiong Wei, Stephen Swisher, Jaffer A Ajani, James D Cox, Ritsuko Komaki.   

Abstract

PURPOSE: To assess the association of clinical and especially dosimetric factors with the incidence of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiation therapy followed by surgery. METHOD AND MATERIALS: Data from 110 esophageal cancer patients treated between January 1998 and December 2003 were analyzed retrospectively. All patients received concurrent chemoradiotherapy followed by surgery; 72 patients also received irinotecan-based induction chemotherapy. Concurrent chemotherapy was 5-fluorouracil-based and in 97 cases included taxanes. Radiotherapy was delivered to a total dose of 41.4-50.4 Gy at 1.8-2.0 Gy per fraction with a three-dimensional conformal technique. Surgery (three-field, Ivor-Lewis, or transhiatal esophagectomy) was performed 27-123 days (median, 45 days) after completion of radiotherapy. The following dosimetric parameters were generated from the dose-volume histogram (DVH) for total lung: lung volume, mean dose to lung, relative and absolute volumes of lung receiving more than a threshold dose (relative V(dose) and absolute V(dose)), and absolute volume of lung receiving less than a threshold dose (volume spared, or VS(dose)). Occurrence of postoperative pulmonary complications, defined as pneumonia or acute respiratory distress syndrome (ARDS) within 30 days after surgery, was the endpoint for all analyses. Fisher's exact test was used to investigate the relationship between categorical factors and incidence of postoperative pulmonary complications. Logistic analysis was used to analyze the relationship between continuous factors (e.g., V(dose) or VS(dose)) and complication rate. Logistic regression with forward stepwise inclusion of factors was used to perform multivariate analysis of those factors having univariate significance (p < 0.05). The Mann-Whitney test was used to compare length of hospital stay in patients with and without lung complications and to compare lung volumes, VS5 values, and absolute and relative V5 values in male vs. female patients. Pearson correlation analysis was used to determine correlations between dosimetric factors.
RESULTS: Eighteen (16.4%) of the 110 patients developed postoperative pulmonary complications. Two of these died of progressive pneumonia. Hospitalizations were significantly longer for patients with postoperative pulmonary complications than for those without (median, 15 days vs. 11 days, p = 0.003). On univariate analysis, female gender (p = 0.017), higher mean lung dose (p = 0.036), higher relative volume of lung receiving > or = 5 Gy (V5) (p = 0.023), and smaller volumes of lung spared from doses > or = 5-35 Gy (VS5-VS35) (p < 0.05) were all significantly associated with an increased incidence of postoperative pulmonary complications. No other clinical factors were significantly associated with the incidence of postoperative pulmonary complications in this cohort. On multivariate analysis, the volume of lung spared from doses > or = 5 Gy (VS5) was the only significant independent factor associated with postoperative pulmonary complications (p = 0.005).
CONCLUSIONS: Dosimetric factors but not clinical factors were found to be strongly associated with the incidence of postoperative pulmonary complications in this cohort of esophageal cancer patients treated with concurrent chemoradiation plus surgery. The volume of the lung spared from doses of > or = 5 Gy was the only independent dosimetric factor in multivariate analysis. This suggests that ensuring an adequate volume of lung unexposed to radiation might reduce the incidence of postoperative pulmonary complications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242257     DOI: 10.1016/j.ijrobp.2005.08.002

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  57 in total

1.  Analysis of dose-volume parameters predicting radiation pneumonitis in patients with esophageal cancer treated with 3D-conformal radiation therapy or IMRT.

Authors:  Gaurav Kumar; Sheh Rawat; Abhishek Puri; Manoj Kumar Sharma; Pranav Chadha; Anand Giri Babu; Girigesh Yadav
Journal:  Jpn J Radiol       Date:  2011-12-14       Impact factor: 2.374

2.  Helical tomotherapy for radiochemotherapy in esophageal cancer: a preferred plan?

Authors:  Gary Y Yang
Journal:  J Thorac Dis       Date:  2009-12       Impact factor: 2.895

3.  Simultaneous irradiation of the breast and regional lymph nodes in prone position using helical tomotherapy.

Authors:  K Kainz; J White; G-P Chen; J Hermand; M England; X A Li
Journal:  Br J Radiol       Date:  2012-03-28       Impact factor: 3.039

4.  Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer.

Authors:  Andre Konski; Tianyu Li; Michael Christensen; Jonathan D Cheng; Jian Q Yu; Kevin Crawford; Oleh Haluszka; Jeffrey Tokar; Walter Scott; Neal J Meropol; Steven J Cohen; Alan Maurer; Gary M Freedman
Journal:  Radiother Oncol       Date:  2012-06-07       Impact factor: 6.280

Review 5.  Technological advances in radiotherapy for esophageal cancer.

Authors:  Milan Vosmik; Jiri Petera; Igor Sirak; Miroslav Hodek; Petr Paluska; Jiri Dolezal; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

Review 6.  Strategies to reduce pulmonary complications after esophagectomy.

Authors:  Teus J Weijs; Jelle P Ruurda; Grard A P Nieuwenhuijzen; Richard van Hillegersberg; Misha D P Luyer
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

Review 7.  The radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancer.

Authors:  Zhengfei Zhu; Xiaolong Fu
Journal:  Transl Lung Cancer Res       Date:  2015-06

8.  Combining multiple models to generate consensus: application to radiation-induced pneumonitis prediction.

Authors:  Shiva K Das; Shifeng Chen; Joseph O Deasy; Sumin Zhou; Fang-Fang Yin; Lawrence B Marks
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

9.  Preoperative cetuximab, irinotecan, cisplatin, and radiation therapy for patients with locally advanced esophageal cancer.

Authors:  Michael S Lee; Harvey J Mamon; Theodore S Hong; Noah C Choi; Panagiotis M Fidias; Eunice L Kwak; Jeffrey A Meyerhardt; David P Ryan; Raphael Bueno; Dean M Donahue; Michael T Jaklitsch; Michael Lanuti; David W Rattner; Charles S Fuchs; Peter C Enzinger
Journal:  Oncologist       Date:  2013-02-21

10.  Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma.

Authors:  K Fakhrian; M Oechsner; S Kampfer; T Schuster; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2013-02-28       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.